187 related articles for article (PubMed ID: 31271822)
1. Change in Apparent Diffusion Coefficient Is Associated With Local Failure After Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer: A Prospective Clinical Trial.
Sampath S; Rahmanuddin S; Sahoo P; Frankel P; Boswell S; Wong J; Rotter A; Rockne R; Wong J; Park JM
Int J Radiat Oncol Biol Phys; 2019 Nov; 105(3):659-663. PubMed ID: 31271822
[TBL] [Abstract][Full Text] [Related]
2. A Prospective Study of Magnetic Resonance Imaging Assessment of Post-radiation Changes Following Stereotactic Body Radiation Therapy for Non-small Cell Lung Cancer.
Munoz-Schuffenegger P; Kandel S; Alibhai Z; Hope A; Bezjak A; Sun A; Simeonov A; Cho BCJ; Giuliani M
Clin Oncol (R Coll Radiol); 2019 Oct; 31(10):720-727. PubMed ID: 31176537
[TBL] [Abstract][Full Text] [Related]
3. Assessment of treatment response after lung stereotactic body radiotherapy using diffusion weighted magnetic resonance imaging and positron emission tomography: A pilot study.
Shintani T; Matsuo Y; Iizuka Y; Mitsuyoshi T; Umeoka S; Nakamoto Y; Mizowaki T; Togashi K; Hiraoka M
Eur J Radiol; 2017 Jul; 92():58-63. PubMed ID: 28624021
[TBL] [Abstract][Full Text] [Related]
4. Prediction of clinical outcome after stereotactic body radiotherapy for non-small cell lung cancer using diffusion-weighted MRI and (18)F-FDG PET.
Iizuka Y; Matsuo Y; Umeoka S; Nakamoto Y; Ueki N; Mizowaki T; Togashi K; Hiraoka M
Eur J Radiol; 2014 Nov; 83(11):2087-92. PubMed ID: 25174774
[TBL] [Abstract][Full Text] [Related]
5. Response assessment of stereotactic body radiation therapy using dynamic contrast-enhanced integrated MR-PET in non-small cell lung cancer patients.
Huang YS; Chen JL; Hsu FM; Huang JY; Ko WC; Chen YC; Jaw FS; Yen RF; Chang YC
J Magn Reson Imaging; 2018 Jan; 47(1):191-199. PubMed ID: 28480541
[TBL] [Abstract][Full Text] [Related]
6. Diffusion-weighted MRI of the lung at 3T evaluated using echo-planar-based and single-shot turbo spin-echo-based acquisition techniques for radiotherapy applications.
Tyagi N; Cloutier M; Zakian K; Deasy JO; Hunt M; Rimner A
J Appl Clin Med Phys; 2019 Jan; 20(1):284-292. PubMed ID: 30421496
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance imaging for prospective assessment of local recurrence of non-small cell lung cancer after stereotactic body radiation therapy.
Kirshenboim Z; Dan Lantsman C; Appel S; Klug M; Onn A; Truong MT; Marom EM
Lung Cancer; 2023 Aug; 182():107265. PubMed ID: 37327593
[TBL] [Abstract][Full Text] [Related]
8. Apparent diffusion coefficient (ADC) change on repeated diffusion-weighted magnetic resonance imaging during radiochemotherapy for non-small cell lung cancer: A pilot study.
Weiss E; Ford JC; Olsen KM; Karki K; Saraiya S; Groves R; Hugo GD
Lung Cancer; 2016 Jun; 96():113-9. PubMed ID: 27133760
[TBL] [Abstract][Full Text] [Related]
9. Diffusion-weighted MRI improves response assessment after definitive radiotherapy in patients with NSCLC.
Jagoda P; Fleckenstein J; Sonnhoff M; Schneider G; Ruebe C; Buecker A; Stroeder J
Cancer Imaging; 2021 Jan; 21(1):15. PubMed ID: 33478592
[TBL] [Abstract][Full Text] [Related]
10. Inter-scan and inter-observer tumour volume delineation variability on cone beam computed tomography in patients treated with stereotactic body radiation therapy for early-stage non-small cell lung cancer.
Hou Y; Lee S; Agrawal V; Romano J; Baldini EH; Chen AB; Kozono DE; Killoran JH; Wagar M; Hacker FL; Aerts HJ; Lewis JH; Mak RH
J Med Imaging Radiat Oncol; 2017 Feb; 61(1):93-98. PubMed ID: 27709803
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer: A Primer for Radiologists.
Febbo JA; Gaddikeri RS; Shah PN
Radiographics; 2018; 38(5):1312-1336. PubMed ID: 30074857
[TBL] [Abstract][Full Text] [Related]
12. Mean apparent diffusion coefficient in a single slice may predict tumor response to whole-brain radiation therapy in non-small-cell lung cancer patients with brain metastases.
Zhao L; Zhao M; Liu J; Yang H; Zhou X; Wen C; Li G; Duan Y
Eur Radiol; 2021 Aug; 31(8):5565-5575. PubMed ID: 33452628
[TBL] [Abstract][Full Text] [Related]
13. Evaluation for local failure by 18F-FDG PET/CT in comparison with CT findings after stereotactic body radiotherapy (SBRT) for localized non-small-cell lung cancer.
Takeda A; Kunieda E; Fujii H; Yokosuka N; Aoki Y; Oooka Y; Oku Y; Ohashi T; Sanuki N; Mizuno T; Ozawa Y
Lung Cancer; 2013 Mar; 79(3):248-53. PubMed ID: 23246123
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer Tumors Greater Than 5 cm: Safety and Efficacy.
Woody NM; Stephans KL; Marwaha G; Djemil T; Videtic GM
Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):325-31. PubMed ID: 25841625
[TBL] [Abstract][Full Text] [Related]
15. Associations of Radiomic Data Extracted from Static and Respiratory-Gated CT Scans with Disease Recurrence in Lung Cancer Patients Treated with SBRT.
Huynh E; Coroller TP; Narayan V; Agrawal V; Romano J; Franco I; Parmar C; Hou Y; Mak RH; Aerts HJ
PLoS One; 2017; 12(1):e0169172. PubMed ID: 28046060
[TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography combined with diagnostic chest computed tomography enhances detection of regional recurrence after stereotactic body radiation therapy for early stage non-small cell lung cancer.
Ebright MI; Russo GA; Gupta A; Subramaniam RM; Fernando HC; Kachnic LA
J Thorac Cardiovasc Surg; 2013 Mar; 145(3):709-15. PubMed ID: 23317944
[TBL] [Abstract][Full Text] [Related]
17. Detection of Local Cancer Recurrence After Stereotactic Ablative Radiation Therapy for Lung Cancer: Physician Performance Versus Radiomic Assessment.
Mattonen SA; Palma DA; Johnson C; Louie AV; Landis M; Rodrigues G; Chan I; Etemad-Rezai R; Yeung TP; Senan S; Ward AD
Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1121-8. PubMed ID: 26907916
[TBL] [Abstract][Full Text] [Related]
18. Estimation of optimal b-value sets for obtaining apparent diffusion coefficient free from perfusion in non-small cell lung cancer.
Karki K; Hugo GD; Ford JC; Olsen KM; Saraiya S; Groves R; Weiss E
Phys Med Biol; 2015 Oct; 60(20):7877-91. PubMed ID: 26406921
[TBL] [Abstract][Full Text] [Related]
19. Circulating Tumor Cell Assessment in Presumed Early Stage Non-Small Cell Lung Cancer Patients Treated with Stereotactic Body Radiation Therapy: A Prospective Pilot Study.
Frick MA; Kao GD; Aguarin L; Chinniah C; Swisher-McClure S; Berman AT; Levin WP; Cengel KA; DeCesaris C; Hahn SM; Dorsey JF; Simone CB
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(3):536-542. PubMed ID: 30244877
[TBL] [Abstract][Full Text] [Related]
20. The Impact of Diffusion-Weighted MRI on the Definition of Gross Tumor Volume in Radiotherapy of Non-Small-Cell Lung Cancer.
Fleckenstein J; Jelden M; Kremp S; Jagoda P; Stroeder J; Khreish F; Ezziddin S; Buecker A; Rübe C; Schneider GK
PLoS One; 2016; 11(9):e0162816. PubMed ID: 27612171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
